- Areas of Research/Scholarship Focus: Epilepsy/Tuberous Sclerosis/Sturge-Weber Syndrome
- Board Certification(s): Child Neurology/Clinical Neurophysiology and Epilepsy
- Medical School: University of Santo Tomas
- Internship: Children's Hospital of Michigan
- Residency: Children's Hospital of Michigan
- Fellowship: Children's Hospital of Michigan
- Awards/Honors:
- Detroit Top Docs 2019, 2020, 2021
- Children's Hospital of MI
3901 Beaubien - 3rd Floor
Detroit MI, 48201 - Phone Number: (313) 745-5906
Practice Fax: (313) 745-0955
Dr. Aimee F. Luat is Division Chief of Pediatric Neurology at the Children’s Hospital of Michigan and a Professor of Pediatrics at Central Michigan University College of Medicine. She is a board-certified pediatric neurologist, clinical neurophysiologist, and epileptologist with extensive training in pediatric neurology and epilepsy. Dr. Luat is widely recognized for her expertise in the evaluation and management of pediatric epilepsy and complex neurological disorders, including tuberous sclerosis complex and Sturge-Weber syndrome. She has played a central leadership role in multidisciplinary clinical programs, including co-directing the Tuberous Sclerosis Clinic and the Epilepsy Surgery Program.
Dr. Luat is an accomplished clinician-scientist with a strong record of peer-reviewed publications, book chapters, and NIH-funded collaborative research focused on neuroimaging, epilepsy, and neurodevelopmental outcomes. She has been consistently recognized for excellence in clinical care and education, including multiple “Top Doctors” honors and institutional teaching awards. In addition to her research and clinical leadership, she is deeply committed to training the next generation of physicians and advancing patient-centered, multidisciplinary care for children with neurological disorders.
Selected Publications
1. Preliminary prospective study of pharmaceutical-grade cannabidiol for seizure frequency, anxiety, and comorbid symptoms in pediatric epilepsy: Associations with circulating endocannabinoids and lipid biomarkers (2026)
Links:
Journal of Child Neurology — Article
2. Introduction of a Brain MRI Scoring System with Clinical Relevance for Sturge-Weber Syndrome (2026)
Links:
PubMed |
Publisher Article
3. Pharmaceutical-Grade Cannabidiol in Pediatric Epilepsy — Cannabis and the Developing Brain (2025)
Links:
Springer — Book Chapter
4. Deep Venous Remodeling in Unilateral Sturge-Weber Syndrome: Robust Hemispheric Differences and Clinical Correlates (2023)
Links:
PubMed |
PubMed Central
5. Neurological Complications of Sturge-Weber Syndrome: Current Status and Unmet Needs (2019)
Links:
PubMed
6. Cognitive and motor outcomes in children with unilateral Sturge-Weber syndrome: Effect of age at seizure onset and side of brain involvement (2018)
Links:
PubMed
7. Corpus Callosotomy for Intractable Epilepsy Revisited: The Children’s Hospital of Michigan Series (2017)
Links:
PubMed |
PubMed Central
